There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Dengue virus (DENV) causes disease ranging from dengue fever (DF), a self-limited
febrile illness, to the potentially lethal dengue hemorrhagic fever and dengue shock
syndrome (DHF/DSS). DHF/DSS usually occurs in patients who have acquired DENV-reactive
antibodies prior to infection, either from a previous infection with a heterologous
DENV serotype or from an immune mother. Hence, it has been hypothesized that subneutralizing
levels of antibodies exacerbate disease, a phenomenon termed antibody-dependent enhancement
(ADE). However, given the lack of suitable animal models for DENV infection, the mechanism
of ADE and its contribution to pathology remain elusive. Here we demonstrate in mice
that DENV-specific antibodies can sufficiently increase severity of disease so that
a mostly nonlethal illness becomes a fatal disease resembling human DHF/DSS. Antibodies
promote massive infection of liver sinusoidal endothelial cells (LSECs), resulting
in increased systemic levels of virus. Thus, a subprotective humoral response may,
under some circumstances, have pathological consequences.
2010 Elsevier Inc. All rights reserved.